176 related articles for article (PubMed ID: 22585407)
1. The value of visfatin in the prediction of metabolic syndrome: a multi-factorial analysis.
Esteghamati A; Morteza A; Zandieh A; Jafari S; Rezaee M; Nakhjavani M; Jamali A; Esteghamati AR; Khalilzadeh O
J Cardiovasc Transl Res; 2012 Aug; 5(4):541-6. PubMed ID: 22585407
[TBL] [Abstract][Full Text] [Related]
2. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
[TBL] [Abstract][Full Text] [Related]
3. Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome.
Chedraui P; Pérez-López FR; Escobar GS; Palla G; Montt-Guevara M; Cecchi E; Genazzani AR; Simoncini T;
Maturitas; 2014 Sep; 79(1):86-90. PubMed ID: 25015014
[TBL] [Abstract][Full Text] [Related]
4. Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients.
El-Hini SH; Mohamed FI; Hassan AA; Ali F; Mahmoud A; Ibraheem HM
Rheumatol Int; 2013 Sep; 33(9):2283-9. PubMed ID: 23471745
[TBL] [Abstract][Full Text] [Related]
5. Serum visfatin levels do not increase in post-menopausal women with metabolic syndrome.
Güdücü N; İsçi H; Görmüş U; Yiğiter AB; Dünder İ
J Endocrinol Invest; 2013 Mar; 36(3):157-61. PubMed ID: 23538464
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity.
Dikbas O; Tosun M; Bes C; Tonuk SB; Aksehirli OY; Soy M
Int J Rheum Dis; 2016 Jul; 19(7):672-7. PubMed ID: 25196858
[TBL] [Abstract][Full Text] [Related]
7. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
[TBL] [Abstract][Full Text] [Related]
8. Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).
Mohan V; Deepa R; Pradeepa R; Vimaleswaran KS; Mohan A; Velmurugan K; Radha V
Metabolism; 2005 Apr; 54(4):476-81. PubMed ID: 15798954
[TBL] [Abstract][Full Text] [Related]
9. Intensive glycemic control lowers plasma visfatin levels in patients with type 2 diabetes.
Zhu J; Schott M; Liu R; Liu C; Shen B; Wang Q; Mao X; Xu K; Wu X; Schinner S; Papewalis C; Scherbaum WA; Liu C
Horm Metab Res; 2008 Nov; 40(11):801-5. PubMed ID: 18686225
[TBL] [Abstract][Full Text] [Related]
10. Visfatin and insulin levels and cigarette smoking are independent risk factors for hidradenitis suppurativa: a case-control study.
Akdogan N; Alli N; Uysal PI; Topcuoglu C; Candar T; Turhan T
Arch Dermatol Res; 2018 Dec; 310(10):785-793. PubMed ID: 30293125
[TBL] [Abstract][Full Text] [Related]
11. Role of body composition and metabolic profile in Barrett's oesophagus and progression to cancer.
Di Caro S; Cheung WH; Fini L; Keane MG; Theis B; Haidry R; Di Renzo L; De Lorenzo A; Lovat L; Batterham RL; Banks M
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):251-60. PubMed ID: 26671515
[TBL] [Abstract][Full Text] [Related]
12. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
[TBL] [Abstract][Full Text] [Related]
13. Glycated Hemoglobin, Fasting Insulin and the Metabolic Syndrome in Males. Cross-Sectional Analyses of the Aragon Workers' Health Study Baseline.
Saravia G; Civeira F; Hurtado-Roca Y; Andres E; Leon M; Pocovi M; Ordovas J; Guallar E; Fernandez-Ortiz A; Casasnovas JA; Laclaustra M
PLoS One; 2015; 10(8):e0132244. PubMed ID: 26241903
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of adiponectin, leptin, resistin and visfatin in non-diabetics patients with hidradenitis suppurativa.
González-López MA; Vilanova I; Ocejo-Viñals G; Arlegui R; Navarro I; Guiral S; Mata C; Pérez-Paredes MG; Portilla V; Corrales A; González-Vela MC; González-Gay MA; Blanco R; Hernández JL
Arch Dermatol Res; 2020 Oct; 312(8):595-600. PubMed ID: 31786710
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin and visfatin levels in extremely low birth weight infants; they are also at risk for insulin resistance.
Cekmez F; Canpolat FE; Pirgon O; Aydemir G; Tanju IA; Genc FA; Tunc T; Aydinöz S; Yildirim S; Ipcioglu OM; Sarici SU
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):501-6. PubMed ID: 23467949
[TBL] [Abstract][Full Text] [Related]
16. Serum visfatin levels in a group of Egyptian obese individuals.
Reda R; Shehab A; Soliman D; Gabr A; Abbass A
Egypt J Immunol; 2011; 18(1):25-32. PubMed ID: 23082477
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome.
Filippatos TD; Derdemezis CS; Kiortsis DN; Tselepis AD; Elisaf MS
J Endocrinol Invest; 2007 Apr; 30(4):323-6. PubMed ID: 17556870
[TBL] [Abstract][Full Text] [Related]
18. Visfatin Levels May be an Early Marker of Atherosclerosis in Patients with Acromegaly.
Piskinpasa H; Okuturlar Y; Dogansen SC; Akdeniz YS; Esen A; Sadri S; Pirhan O; Gemici AA; Serin SO; Gedikbası A; Adas M; Mert M
Horm Metab Res; 2019 Oct; 51(10):649-654. PubMed ID: 31487747
[TBL] [Abstract][Full Text] [Related]
19. [Visfatin in obese patients, relation with cardiovascular risk factors, a cross sectional study].
de Luis DA; Ballesteros M; Ruiz E; Muñoz C; Penacho A; Iglesias P; Guzmán AL; Abreu C; Maldonado A; Delgado M; Martín LS; Puigdevall V; Romero E; Sagrado MG; Izaola O; Conde R;
Med Clin (Barc); 2011 Jul; 137(5):199-203. PubMed ID: 21296365
[TBL] [Abstract][Full Text] [Related]
20. Adipocytokines in primary antiphospholipid syndrome: potential markers of low-grade inflammation, insulin resistance and metabolic syndrome.
Rodrigues CE; Vendramini MB; Bueno C; Bonfá E; de Carvalho JF
Clin Exp Rheumatol; 2012; 30(6):871-8. PubMed ID: 22935544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
